Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional inte...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fatemeh Yavari, Pardis Oliazadeh, Meisam Radfar, Mohsen Foroughipour, Karim Nikkhah, Alireza Heidari Bakavoli, Morteza Saeidi
Format:	Artigo
Idioma:	Inglês
Publicat:	Iran University of Medical Sciences 2021-03-01
Col·lecció:	Basic and Clinical Neuroscience
Matèries:	multiple sclerosis fingolimod expanded disability status scale (edss) magnetic resonance imaging (mri) cardiovascular events therapy
Accés en línia:	http://bcn.iums.ac.ir/article-1-1412-en.html
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!